BACKGROUND & AIMS: Intestinal dysmotility is a component of many neurodegenerative disorders, including some characterized by neuronal intranuclear inclusions. PrP-SCA7-92Q transgenic mice phenocopy many aspects of the human polyglutamine neurodegenerative disorder spinocerebellar ataxia type 7 (SCA7). The enteric neuropathology of PrP-SCA7-92Q mice was investigated after observing that they develop signs of intestinal pseudo-obstruction. METHODS: Gastrointestinal transit of radio-opaque pellets through presymptomatic and symptomatic PrP-SCA7-92Q mice and nontransgenic littermates was compared. Gross, microscopic, and ultrastructural studies were conducted, along with histologic and whole mount immunohistochemistry, to identify intranuclear inclusions and quantify subsets of enteric neurons. Immunoblot analysis was performed to confirm selective loss of particular neuronal populations. RESULTS: A subset of cholinergic enteric ganglion cells in PrP-SCA7-92Q mice harbor nuclear inclusions composed of transgene-derived ataxin-7, which contains a pathogenic polyglutamine expansion. These animals die between 15 and 20 weeks of age with intestinal distension and enterocolitis. Signs of disease are preceded by selective loss of nitric oxide synthase-positive neurons (which lack nuclear inclusions), loss of nerve fibers in the myenteric nerve plexus, and delayed gastrointestinal transit. Cholinergic neurons, including those with inclusions, are spared. CONCLUSIONS: PrP-SCA7-92Q mice may be useful models for human intestinal pseudoobstruction, particularly visceral neuropathies with neuronal intranuclear inclusions. Loss of inclusion-free inhibitory neurons supports the hypothesis that inclusions may be neuroprotective or coincidental, as opposed to harbingers of neuron death. Because enteric neuropathology in PrP-SCA7-92Q animals is easily missed by routine histopathology, quantitative immunohistochemical approaches may be required to recognize analogous forms of human enteric neuropathy.
BACKGROUND & AIMS:Intestinal dysmotility is a component of many neurodegenerative disorders, including some characterized by neuronal intranuclear inclusions. PrP-SCA7-92Q transgenic mice phenocopy many aspects of the humanpolyglutamine neurodegenerative disorder spinocerebellar ataxia type 7 (SCA7). The enteric neuropathology of PrP-SCA7-92Q mice was investigated after observing that they develop signs of intestinal pseudo-obstruction. METHODS: Gastrointestinal transit of radio-opaque pellets through presymptomatic and symptomatic PrP-SCA7-92Q mice and nontransgenic littermates was compared. Gross, microscopic, and ultrastructural studies were conducted, along with histologic and whole mount immunohistochemistry, to identify intranuclear inclusions and quantify subsets of enteric neurons. Immunoblot analysis was performed to confirm selective loss of particular neuronal populations. RESULTS: A subset of cholinergic enteric ganglion cells in PrP-SCA7-92Q mice harbor nuclear inclusions composed of transgene-derived ataxin-7, which contains a pathogenic polyglutamine expansion. These animals die between 15 and 20 weeks of age with intestinal distension and enterocolitis. Signs of disease are preceded by selective loss of nitric oxide synthase-positive neurons (which lack nuclear inclusions), loss of nerve fibers in the myenteric nerve plexus, and delayed gastrointestinal transit. Cholinergic neurons, including those with inclusions, are spared. CONCLUSIONS:PrP-SCA7-92Q mice may be useful models for human intestinal pseudoobstruction, particularly visceral neuropathies with neuronal intranuclear inclusions. Loss of inclusion-free inhibitory neurons supports the hypothesis that inclusions may be neuroprotective or coincidental, as opposed to harbingers of neuron death. Because enteric neuropathology in PrP-SCA7-92Q animals is easily missed by routine histopathology, quantitative immunohistochemical approaches may be required to recognize analogous forms of human enteric neuropathy.
Authors: Douglas G Howe; Christine M Clarke; Huijun Yan; Brandon S Willis; David A Schneider; G Stanley McKnight; Raj P Kapur Journal: J Neurobiol Date: 2006-02-15
Authors: G David; A Dürr; G Stevanin; G Cancel; N Abbas; A Benomar; S Belal; A S Lebre; M Abada-Bendib; D Grid; M Holmberg; M Yahyaoui; F Hentati; T Chkili; Y Agid; A Brice Journal: Hum Mol Genet Date: 1998-02 Impact factor: 6.150
Authors: J Amiel; T Attié; D Jan; A Pelet; P Edery; C Bidaud; D Lacombe; P Tam; J Simeoni; E Flori; C Nihoul-Fékété; A Munnich; S Lyonnet Journal: Hum Mol Genet Date: 1996-03 Impact factor: 6.150
Authors: Ian A Parish; Lincon A Stamp; Ayla May D Lorenzo; Suzanne M Fowler; Yovina Sontani; Lisa A Miosge; Debbie R Howard; Christopher C Goodnow; Heather M Young; John B Furness Journal: Am J Pathol Date: 2016-07-16 Impact factor: 4.307
Authors: Alan J Burns; Allan M Goldstein; Donald F Newgreen; Lincon Stamp; Karl-Herbert Schäfer; Marco Metzger; Ryo Hotta; Heather M Young; Peter W Andrews; Nikhil Thapar; Jaime Belkind-Gerson; Nadege Bondurand; Joel C Bornstein; Wood Yee Chan; Kathryn Cheah; Michael D Gershon; Robert O Heuckeroth; Robert M W Hofstra; Lothar Just; Raj P Kapur; Sebastian K King; Conor J McCann; Nandor Nagy; Elly Ngan; Florian Obermayr; Vassilis Pachnis; Pankaj J Pasricha; Mai Har Sham; Paul Tam; Pieter Vanden Berghe Journal: Dev Biol Date: 2016-04-05 Impact factor: 3.582
Authors: Yuxing Xia; Stefan Prokop; Brach M Bell; Kimberly-Marie M Gorion; Cara L Croft; Lith Nasif; Guilian Xu; Cara J Riffe; Alyssa N Manaois; Kevin H Strang; Stephan S Quintin; Giavanna Paterno; Malú Gámez Tansey; David R Borchelt; Todd E Golde; Benoit I Giasson Journal: Commun Biol Date: 2022-05-12
Authors: Sarah Herdewyn; Carla Cirillo; Ludo Van Den Bosch; Wim Robberecht; Pieter Vanden Berghe; Philip Van Damme Journal: Mol Neurodegener Date: 2014-06-17 Impact factor: 14.195